Member Info for Aldebaran

There was more than 1 predicting that. The ramps have just got out of control.

If the science continues to impress then HEMO is going to do really really REALLY well from this level. Not in a straight line though and much more time and data is required.

With an anticipated lul in newsflash whilst we wait for the safety data review and then identification of next patients then CAR-T cell production for them there will be an inevitable news vacuum. One which i have been hoping Vlad will fill with some kind of investor webinar or at the very least a proactive interview. Alas I dont think he will and there seems to be no appetite for one.

None of the big money people at these events have evidently seen or heard enough to start insider buying so with RSI still oversold, bearish RSI divergence, bearish candlestick patterns and price failing to close above critical resistance of 1600p, my assumption of this falling back to around 1000p looks more certain now.

Of course the usual zealots will jump on this post, attack me as being short or part of a gang or whatever and of course they'll all back slap anyone and recommend the posts which say this is going to the moon tomorrow but its all par for the course.

This fan page prefers convenient ramps than inconvenient truths. Short term, odds on this drops now as traders move their pots to other stocks in the short term at least.

At start of the day I said this would either motor on past 1600p or its would be a sell on news day. That has now been answered.

Cyrox, there are those of us who predicted this exact price action. And there are those of us who insisted this was headed to 24quid today.

One of the posters gets slated and abused, accused of shorting etc while the other showered in recommendations. What do you prefer, inconvenient truths or convenient lies?

I agree with most of that JHFH. Only things of ambiguity are the price of treatment, given those price tags im not sure how many CAN afford to self fund or if the patients health insurance covers costs of unapproved treatments in different countries and secondly what portion of this cost will be going to cellin. 50% ?

I think the markets subdued reaction says it all. Pretty much what I said before market opened. Its positive news but hasn't blown me away.

I take Haywains points also that efficacy for CAR-T is front loaded however when pharmaceutical companies are spending hundreds of millions or more they want absolute certainty or as close to it as possible. We're just not there yet but if all continues to go well we should be by Q1 2026.

Big pharma aren't queuing around the block with there check books, they aren't bothered who hemo talk to, they are not worried this isnt an eBay auction ffs. They'll do there due diligence, work out the value, discount it back on a risk adjusted basis, take off development costs etc and make an offer. If another big pharma makes a counter offer then it gets interesting.

Anyway, in the meantime we now need to wait for safety data review and Vlad should be updating investors with a webinar. Hopefully he comes out this week and announces one or the fear uncertainty and doubt will rise IMO

Wait, so i have an alternative account. I am short and also looking to buy in cheaper and I put on blocking trades. One guy blamed me for the company not being 25% more higher valued..

Has any of you ever stopped to think about what your posting lol

I am guessing you've had a lot of nonsense here over the years so have become scarred by it all. I pitty you actually if thats the case.

Anyway, believe what you want. Yes 1600p is the price we need to close above from a technical POV to send this higher. Towards 3000p would be my target.

I thought with this game changing paradigm shifting news today you lot would have been throwing the kitchen sink in. No? Guess your saying one thing and doing another. Hence why I believe price action above all else. Like you guys I am also scarred from investing in small caps these past few years. I dont trust anything or anyone anymore and company's are guilty til proven innocent.

Ever since I adopted this approach ive done really well. Oh and rolls royce ten bagged for me lol

Not posting you've made the mistake I made in believing this is a discussion board for all views to be debated, challenged, built upon etc..

This is a fan page.

FWIW, I think this is a positive development and the fact near term revenues are possible, no matter how small is big plus also.

It's not going to lead to a lot commercially and still isnt binding and could fall through during talks etc... and unfortunately the go hemo go mob ramped this summit in DC & NYC so hard they have set sky high expectations and this announcement doesn't come close to what they were expecting and promising others.

Stay grounded I say and dont be afraid to go against the mob here. Their just a bunch of anonymous names on a screen all pretending they're best mates with each other. Funny

Not posting i am in full agreement with your last post.

Its undoubtedly good news. Let's see where we go from here

I didnt realise that actually so ill have to look into it. If I made a mistake on that front fair enough and thanks for highlighting

Zero upfront costs but they won't be doing this for free. The number of patients per year with rr AML in Estonia is tiny also. Its positive news but you're getting ahead of yourselves again.

Positive news but was expecting more from this summit given the ramps on here. One guy recently was saying he thought the people at DC would be getting nervous that vlad is presenting in NYC for example...

Let's just keep it real kids and anyway the share price will do the talking so we'll know by end of the day if what you people are saying is what you are doing I.e. scrambling around to buy more and top up etc etc

Let's see how the share price responds. A close above 1600p or a sell on news day. All im saying is that this announcement isnt blowing me away.

Its a non-binding letter of intent between HEMO & a small private company based in Estonia. In a nutshell I think it shows great confidence in the treatment from them and hemo and potential early revenues from 2026 is great. I just hoped for something more firm and bigger.

The bulk of people here were claiming big pharma will have there cheque books out queuing around the block etc etc so you've set yourself and others up for disappointment with this i feel.

Let us see. Brake above and close above 1600p ill be buying my half back at a higher price than I sold. Sucks.

Sell on news day, I get my 1000p target re entry price. Happy days. I dont mind which scenario to be frank but I SUSPECT the latter

This is why i kept half my pot here. That said, i do have mixed feelings about this as in its only a LOI and I did expect or should I say hope for more from Vlads latest meetings. Perhaps more is to come?

No idea who this guy is or why this is relevant now? If he was in on the IPO and is a serial pump and dumper then I would guess he has done his pump and his dump a long while ago and no longer holds shares. Certainly he doesn't hold above 3% so what's the fuss? I dont think this should carry any weight good or bad for new investors today

Davie_b asking basic questions shouldn't cause anguish to investors and if it does quite frankly fcuk them. Ask away, this is a discussion board not a fan page and an investment not a religion. You've no doubt worked hard for your money and rightly want to protect it. Lot of nasty people on this bored but there are a few who are helpful and dont view every question or comment through the lens of some evil manipulator is trying to organise a short attack in collusion with the mm's lmao.

If you took comfort and reassurance from Haywains reply, then so did I. Thats all we needed and exactly what these boards should be for.

Now there are a lot invested or trading who dont use these boards and they probably have same concerns as we did. Hence why it would be super useful for Vlad to come out and give a presentation to investors now cohort 1 is complete and just explain a few basics to EVERYONE.

Anyone who thinks that's a bad idea or me deliberately deramping or whatever is insane and lost all objectivity

Thats encouraging to read Haywain thanks.

I still think it would be useful for Vlad to come out and explain this to the market and provide an update for everyone though.

Maybe to the FDA but not to us shareholders as far as I can tell. Ive googled and used AI and ive found nothing which says we have to be informed.

Doesn't mean for one second they are deceased of course. Its just that with median survival measured in months it would be useful to know and Vlad missed a trick in his last RNS.

Imagine if that RNS came out and said "patient 3 has no detectable cancer cells by standard methods, more detailed tests are underway and the results will be announced within 1 week. In addition, patient 1 and patient 2 remain alive at 7 and 4 months with minimal side effects and still no evidence of their cancer returning. The safety data team are currently reviewing cohort 1 data and we expect the results to be issued within the next 3 weeks. Patient 4 and pediatric patient 1 selection is actively ongoing and on results of favourable safety data we will commence dosing within 1 week"

The share price would rocket. Thats what i want. Thats what we all want i thought.

Vlad needs to take his head out of the microscope and start acting and thinking like the CEO of an 80m public company

You don't seem to be able to realise the difference between reporting to the FDA and feeding back to shareholders Archbishop...

Im not saying the patience are dead by the way. On the contrary I get the feeling things are going well but why did Vlad not mention them in the last update. What was the special permission needed for when dosing patient 3 as well?

We have questions and they should be answered. This is a PLC, not Vlads private science experiment.

I you think thats an unreasonable position to take then you've completely lost all objectivity

I can barely keep up with the insults here lol

Trying to manipulate price? Come on guys. This is a discussion board. Someone (not me) asked a question about patient 1 and 2. I thought it was a reasonable question.

Frankly I dont care if you think im in, out , partially out, shorting or whatever. Ive told you my position believe it or not im completely past caring and won't be defending it any more as you don't believe it anyway so believe what makes you feel better.

Thank you for believing I have the power to manipulate the share price of an 80m pound company. I'm honoured. Its nonsense of course but yeah you think that.

Bottom line, the questions raised could and should be addressed by Vlad in a webinar and its not being. Why the silence. I find that a little suspicious if nothing else.

Pwil hi. I just looked into this and only deaths directly related to treatment have to be reported "as soon as possible" if determined to be material. With media survival currently 2-4 months and patient 1 alive 7 months and patient 2 alive 4 months then any deaths at this point or should I say within the past month I doubt would be considered material and so not reported.

Chances are they are still doing fine. I just dont like the ambiguity. They were reported fine last month and then in the latest update no mention of them. As I said before I suspect everything. Guilty until proven innocent

Pwil3150. I didnt know that 5 day rule. If thats true. It shuts me up instantly and answers Davie_B question so thank you.

Do you have a source for that information is all id ask now. If I can verify it then id be back to bullish as opposed to currently on the fence.

Thanks

"Preliminary assessment shows that original AML cells were not detectable in the patient using standard testing methods. "

Great 👍

But... its akin to looking for near earth objects with a pair of binoculars. Use the James Webb space telescope however and you can see a lot more. This is what is required, detailed blood work to confirm for certain there is no residual cancer. When will we get those results, does anyone know?

Feel like Vlad is selectively releasing information and the zealots are jumping up and down in excitement rather than critically analysing.

Its very positive dont get me wrong but far from conclusive. Let's have an investor event and clear all this up. The FUD would disappear instantly and share price rocket. If you're all right of course...

All the below is correct and its a very exciting time to be invested in HEMO. I can prove it is significantly undervalued also by at least. AT LEAST 50% undervalued.

Its a simple few question though

Are patients 1 and 2 STILL alive?

Has their cancer returned yet?

When will we get the detailed results from P3 bloodwork?

What are the timelines to the next steps including safety data review and pediatric dose start?

How did the conversations go in DC, can you share any insights.

I think all the above are reasonable questions and could/should be addressed via an investor webinar. How can anyone sensible disagree? Unless you don't want those questions inserted because you fear the response, that is the only explanation that makes sense to me right now